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TheQuartz CrystalMicrobalance with dissipation (QCM-D) techniquewas applied tomonitor and quantify
integrin-RGD recognition during the early stages of cell adhesion. Using QCM-D crystals modified with a
photo-activatable RGD peptide, the time point of presentation of adhesive ligand at the surface of the
QCM-D crystal could be accurately controlled. This allowed temporal resolution of early integrin-RGD
binding and the subsequent cell spreading process, and their separate detection by QCM-D. The specificity
of the integrin-RGD binding event was corroborated by performing the experiments in the presence of
soluble cyclicRGD as a competitor, and cytochalasin D as inhibitor of cell spreading. Larger frequency
change in the QCM-D signal was observed for cells with larger spread area, and for cells overexpressing
integrin avb3 upon stable transfection. This strategy enables quantification of integrin activity which, in
turn, may allow discrimination among different cell types displaying distinct integrin subtypes and
expression levels thereof. On the basis of these findings, we believe the strategy can be extended to other
photoactivatable ligands to characterize cell membrane receptors activity, a relevant issue for cancer
diagnosis (and prognosis) as other several pathologies.
I ntegrins are the major adhesive receptors that support cell attachment and migration
1. The type, density, and
affinity of integrins define the adhesive properties of a cell towards the extracellular matrix or a defined
biomaterial2. The overall integrin activity profile of a cell is in balance with the cellular microenvironment,
being altered in many pathological cases3–5. Particularly, during cancer progression integrin aVb3 is overex-
pressed on many tumor cells4,6, promoting, for instance, metastasis in breast cancer7, reason why this type of
integrins were used as a therapeutic target8,9. Furthermore, priming of integrins by protein Rap1 promotes
prostate cancer metastasis10, indicating that not only the expression but also the activity of integrins is a key
factor in disease development and progression. Understanding integrin expression patterns and priming
mechanisms that regulate cell adhesion andmigration/invasion, and how they correlate with disease development
and progression may provide new diagnostic tools, in particular for cancer.
Quantification of cell adhesion events using acoustic and electric crystal resonators has been reported11–16.
Using the quartz crystalmicrobalance with dissipation (QCM-D)method, cell attachment to the crystal resonator
is reflected as a decrease in frequency and an increase in dissipation signals, indicating an increase in mass and
viscoelasticity of the surface layer17–21. However, the information obtained by QCM-D studies has so far been of
rather limited use, since the QCM-D signal reflects an uncorrelated measure of cell sedimentation, attachment,
and spreading occurring at different time scales. These events are not synchronized among the cell population and
they cannot be differentiated in the QCM-D curve.
Cell sedimentation takes place within a time scale of seconds to a few minutes depending on cell-substrate
interactions22,23. Cell sedimentation approaches the cell membrane to the surface and enables specific binding of
membrane integrins to adhesive ligands at the surface. Subsequently, integrin clustering, focal adhesion (FA)
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QCM-D signal reflects the sum of all these processes across the
QCM-D sensor surface starting from the time point of cell injection
into the QCM-D chamber.We hypothesized that in order to obtain a
QCM-D signal characteristic for the integrin binding event, the
integrin ligand should be made available to the cells at a defined time
point once cell sedimentation has been accomplished. This could
generate a time window for detection and quantification of the initial
integrin-ligand recognition event, which would reflect integrin
expression levels, affinity, and clustering.
Many integrin receptors recognize and bind to the short RGD
peptide sequence, and this recognition has been widely exploited
to direct drug targeting8,9,24, integrin imaging25, and cell adhesion,
isolation and migration26–31. We have recently developed a photo-
activatable variant of the cyclo[RGDfK] cell adhesive peptide, c[RGD
(DMNPB)fK] (Figure 1a), that allows light-triggered activation of
RGD sites at a surface in the presence of cells32. Integrin-RGD-
mediated cell attachment, spreading, and migration onto surfaces
functionalized with c[RGD(DMNPB)fK] was initiated after a short
(seconds) light pulse33. In the present study, we usedQCM-D crystals
modified with c[RGD(DMNPB)fK] functionalized self-assembled
monolayers of PEG-thiols in order to monitor integrin binding
events during early cell attachment. Due to the protein adsorption-
resistant PEG coating, the crystals do not allow non-specific integrin
binding to the surface. In situ activation of the RGD ligand by light
exposure allowed us to precisely define the onset for integrin binding,
and a time window to monitor integrin binding separately from
membrane spreading. We demonstrate that the QCM-D signal is
specifically associated to integrin-RGD binding events and correlates
with integrin expression levels. This method allows differentiation
among different cell types, and also among cells from the same type
displaying different integrin expression levels and compositions.
This strategymay open new pathways for sensing and discrimination
between pathogenic and healthy cells by reflecting their overall integ-
rin activity level.
Results
Sequential detection of integrin binding and spreading on QCM-
D crystals functionalized with the photo-activatable RGD peptide
after in situ light exposure. Gold-coated quartz sensors were
functionalized with c[RGD(DMNPB)fK] (Fig. 1a) terminated self-
assembled monolayers (SAMs) and inserted into the QCM-D
chamber. After equilibration with PBS, the crystals were incubated
with a cell suspension (Fig. 1b, i). A slightly decreased frequency and
an increased dissipation signal were noticeable, indicating that cells
deposited on the crystal but did not strongly interact with it. This is in
agreement with the cell repellent properties expected from the
pegylated SAM and the inactive cyclo[RGD(DMNPB)fK]. At some
point, both frequency and dissipation achieved a constant value,
usually after an incubation time of around 40 minutes, indicating
that the cell sedimentation on the crystal was completed (Fig. 1b, ii).
Similar results have been reported using lipid vesicles34,35.
RGD peptide activation was performed by illuminating the QCM-
D crystal for 30 sec with a LED (l5 360 nm) through the window of
the QCM-D chamber (Fig. 1b, iii). UV light cleaves the DMNPB
chromophore and activates the RGD peptide ligand at the sensor
surface. At this point, a pronounced drop in frequency and increase
in the dissipation signals were visible, indicating an increase in mass
and viscoelasticity of the surface layer bound to the crystal. We
attribute this increase in mass and viscoelasticity to coordinated
recognition and binding of the membrane integrins to the activated
RGD ligands on the crystal and subsequent membrane spreading
(Fig. 1b, iv)32,33. The signal reached equilibrium after approx. 2 hours
(Fig. 1c, iv). Importantly, frequency and dissipation changes vary
with the density of the injected cell suspensions (Supplementary
Fig. SI1). The experiments were standardized to a cell concentration
of 33 105 cells/mL. Under these conditions, cells did not exceed 70%
confluence after final spreading on the QCM-D crystal and cell
stacking was prevented.
Upon UV irradiation (t5 0 s), an immediate, 1 Hz jump in the
frequency signal was detected (Fig. 2). The frequency jump dropped
back down when the UV light was turned off (t 5 30 s). The same
effect was observed when the same substrates were irradiated in the
absence of cells, but the frequency signal returned to the original
levels (Supplementary Fig. SI2). We attribute this frequency jump
to photo-induced noise, as previously reported36,37. No correspond-
ing change in the dissipation signal was observed. A , 0.5–1.5 Hz
decay in the frequency signal also occurred during the first 50 sec-
onds (Fig. 2, Df1), although it only became visible after the photo-
induced noise vanished. Simultaneously, the dissipation signal (not
affected by the photo-induced noise) showed an increase starting at t
5 25 s (red arrow, Fig. 2). We reasoned that these changes were
associated with the binding of integrins at the cell membrane to
the activated RGD peptide, which occurred rapidly and reached
steady state for the frequency signal within 1 min. Parallel live cell
microscopy showed that cells flattened during the first 1.5 min after
irradiation, and spread at longer times (Supplementary Movie 1),
suggesting that the regions iii and iv of the QCM-D curve in
figure 1c correspond to integrin binding and the subsequent spread-
ing process separately. These two processes occur at very different
time scales (1–2 min vs 2 h). Notably, these events have not been
observed in previously reported QCM-D measurements of cell-sur-
face interactions using c[RGDfK]17,38. The possibility of in situ activa-
tion of the RGD ligand at the surface once cell sedimentation is
concluded, allows temporal definition of the onset for integrin-
RGD interaction and its detection over the first minute after ligand
exposure.
Specificity of Df1 for integrin binding. In order to prove that the
initial frequency Df1 and associated dissipation changes correspond
to light-mediated integrin-RGD-triggered cell adhesive events, we
performed competition experiments in the presence of soluble
RGD peptide ligand. Soluble RGD competes with surface-bound
RGD ligands for integrin binding and hampers cell attachment to
RGD-functionalized surfaces. Previous work with HT1080 fibroblast
on RGD-modified surfaces demonstrated that adhesion and
spreading were compromised when concentrations of soluble RGD
between 250 and 500 mM were added to the medium29. In our
experiments, the frequency and dissipation signals of a cyclo[RGD
(DMNPB)fK]-modified crystal incubated with HT1080 cells in the
presence of 500 mMsoluble RGDdid not change after light exposure.
This result indicates no binding of the integrins to surface-bound,
light-activated RGD peptide ligands due to blocking of the integrins
by the high concentration of the soluble RGD. Experiments with
lower soluble RGD concentrations showed a significant reduction
in the initialDf1. Figure 3a showsDf1 obtained in the presence of 0 to
50 mMof soluble c[RGDfK]. Increasing concentrations of c[RGDfK]
led to a pronounced decrease of Df1. This result confirms that the
QCM-D signal after light exposure is closely associated to RGD-
mediated integrin binding.
A possible contribution of cell spreading to Df1 was ruled out by
performing similar experiments in the presence of cytochalasin D
(Cyt. D), an inhibitor of actin polymerization that impairs cell
spreading in a concentration-dependent manner22,39,40. Addition of
10 mMCyt. D to the medium did not change Df1 values, confirming
that this signal is mainly attributed to integrin binding and not to
spreading events. In the presence of Cyt. D, no steep drop in fre-
quency was observed at longer incubation times (20 min) as shown
in figure 3b, confirming that cell spreading was the major contri-
bution to the steeper change in frequency. When QCM-D chamber
was washed with PBS, a change in frequency similar to control
experiments was observed, confirming that cells were able to attach
to the substrate when the Cyt. D was removed. These results confirm
www.nature.com/scientificreports
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Figure 1 | (a) Chemical structure of the photo-activatable adhesive peptide ligand c[RGD(DMNPB)fK] and the products generated upon photolysis.
(b) Schematic of the steps to trigger synchronized cell adhesion and spreading. (c) QCM-D measurement of a integrin/RGD-mediated cell binding
process on the c[RGD(DMNPB)fK] crystal. Changes in frequency f (blue line) and dissipationD (red line) through the experiment described in Figure 1b.
i- cell seeding; ii- cell sedimentation; iii- UV irradiation through the window of the QCM-D chamber for RGD peptide activation (magnified inset); iv-
integrin binding and cell spreading.
www.nature.com/scientificreports
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the capacity of the QCM-D technique in combination with photo-
activatable RGD ligands to independently detect and quantify early
integrin binding during cell attachment to the QCM-D crystal.
Df1 correlates with integrin expression levels at the cellmembrane.
Several pathologies, like cancer, are associated with overexpression of
certain integrin subtypes at the cell membrane6,7. Moreover, integrin
inside-out signaling regulates integrin affinity and leads to strong
changes in the cell adhesive strength and cellular behavior41,42. For
instance, metastatic malignancy in prostate cancer is upregulated by
the inside-out activation of the integrins under Rap1 cytoplasmic
expression10, proving to be the key factor of migration regardless
of the integrin levels. Although integrin expression levels can be
analyzed by flow cytometry or immunostaining, the QCM
technique has the potential advantage of revealing integrin
expression levels and activity in the intact, living cell.
In a first attempt to reveal whether different cell types or a par-
ticular integrin expression level may be differentiated by Df1 value,
we compared cell binding experiments using primary HUVEC and
the cell lines HT1080 and OV-MZ-6, respectively. HUVEC and
HT1080 cells are highly responsive to the presence of RGD, as
demonstrated in previous reports33. In order to elucidate the pos-
sibility of measuring different levels of integrin expression, the
ovarian cancer cell line OV-MZ-6 with low endogenous integrin
aVb3 levels was studied and compared with OV-MZ-6 cell transfec-
tants exhibiting elevated integrin aVb3 levels.
Binding assays were performed as described before. For meaning-
ful comparison, equal cell densities in the incubation solution were
used for all cell types. All cell types evaluated showed similar evolu-
tion of the QCM-D signals. In all the cases, an initial small frequency
drop (Df1) was detected after irradiation (Fig. 4a), then the frequency
remains stable for a few seconds (,60 s) before a steeper drop, as a
result of cell membrane spreading, started. Figure 4b shows the Df1
drop obtained for each cell type. HUVEC showed significantly higher
Df1 thanHT1080 cells, most probably due to their larger cell size. The
Df1 observed for OV-MZ-6 aVb3 transfectants was also significantly
higher than for the parental cell line (OV-MZ-6 p), as expected due to
higher numbers of integrin aVb3 expression. These results suggest
that Df1 is a useful parameter when using photo-activatable RGD to
describe the integrin activity of a cell population reflecting expression
levels.
We also performed comparative QCM-D experiments using
HUVEC as well as OV-MZ-6 cells in the presence of blocking
anti-aVb3 antibodies to abrogate the RGD-integrin recognition
event, and also with OV-MZ-6 stably overexpressing integrin
aVb3. HUVEC in the presence of 10 mM anti-aVb3 antibody showed
a 60% decrease in the frequency signalDf1 with respect to the control.
Figure 2 | QCM-D signal and cell morphology changes following photo-
activation of the RGD ligand. Frequency (blue line) and dissipation (red
line) variation shortly before and 2 min after UV light exposure of 30 s
fromminute 0 (black bar).Df1 indicates the frequency dropwithin the first
minute after the lamp was turned on. The red arrow points out the
moment at whichDD increase occurs, after 25 s of lamp irradiation. Lower
panel: phase contrast images showing the morphology of an adhering cell
during the time sequence at 0, 1 and 5 min after irradiation, respectively.
Scale bar 10 mm.
Figure 3 | Integrin binding and not spreading is responsible for Df1. (a) Binding experiments were performed in the presence of increasing
concentrations (0 to 50 mM) of competing soluble RGDfK peptide ligands resulting in monotonic decrease of Df1. (b) Cells treated with Cyt. D were no
longer able to spread after irradiation at minute 1 (blue line), as observed from the unchanged frequency, but were capable of accomplishing firm initial
attachment since they remained immobilized on the substrate upon rinsing the chamber with PBS (minute 15). When adding Cyt. D-free PBS again, the
cells regained their spreading properties again comparable to control cells (black line). Microscopy images confirmed these results by showing cells in a
rounded shape in the presence of Cyt. D, and the usual flattening after a system rinsing with PBS (pictures not shown).
www.nature.com/scientificreports
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Figure 4 | Df1 obtained on different cell types and different integrin expression (a) Changes in frequency produced by RGD activation from minute 0.
Df1 was determined by frequency average (striped lines) obtained from 1 minute after irradiation (marked in top) since frequency remains stable
for at least that interval.WT andavb3 in the figure legend denote theWild type and avb3 transfectant OV-MZ-6 cells. (b)Df1 average obtained forHT1080
(0.618 6 0.128 Hz), HUVECs (0.966 6 0.123 Hz) and OV-MZ-6 avb3 (0.913 6 0.245 Hz) and OV-MZ-6 (0.449 6 0.178) at 3 3 10
5 cells/ml.
Figure 5 | D/f plots modulus and slope may reflect FAs and cell spreading.D/f values of cell spreading (a) with or without 10 mMantibodies directed to
integrin aVb3 onHUVECs. Time progression is indicated with dashed lines. (b) Average of cell spreading progression at different times in the presence or
absence of 10 mM antibodies directed to integrin aVb3. (c) FA per cell after 40 min incubation onto the QCM substrates in the presence or absence of
10 mM antibodies directed to integrin aVb3. Insets contain representative pictures of HUVEC cells showing vinculin-GFP stained FA in green, DAPI
nuclear staining in blue, and TRITC-phalloidin bound to F-actin fibers in red. (d) Representative pictures of cell spreading at 10 and 40 min in the
absence (Control) or presence (anti aVb3) of 10 mM antibodies.
www.nature.com/scientificreports
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The same experiment performed with OV-MZ-6 aVb3 transfectants
gave a 92% decrease in Df1. OV-MZ-6 overexpressing aVb3 gave
a 2-fold increase in Df1 compared to OV-MZ-6 parental cells
(Supplementary Table SI1). These results further demonstrate that
Df1 can be used as a parameter that reflects integrin expression levels
at the cell membrane.
D/f values reflect cell spreading and focal adhesion maturation. The
D/f ratio in the QCM-D signal provides insight into the mechanical
properties of the cell membrane attached to the surface43–46. Concep-
tually, differences in frequency reflect a more direct interaction of the
cell with the substrate, while dissipation changes reflect membrane and
cytoskeletal rearrangement above the membrane in close contact with
the substrate. Previous research provides some experimental evidence
for these assumptions19,38 though the parallel occurrence of cell
sedimentation, integrin binding, and cell spreading precludes unam-
biguous interpretation so far.
In an attempt to correlate observable parameters of cell adhesion
with the D/f plots during spreading, we analyzed the D/f plots of the
attachment of HUVEC in presence or absence of anti aVb3 blocking
antibodies (10 mM) (Fig. 5a). In parallel, we analyzed the spreading
area and FA formation by fluorescence microscopy. Significantly
lower D/f values were obtained in the presence of aVb3 blocking
antibodies, indicating a relationship between D/f at a particular time
after exposure and the ability of the cells to adhere and spread.
Interestingly, quantification of the area occupied by the cells after
spreading (Fig. 5b) showed only ca. 20% lower spreading of the cells
treated with the aVb3 blocking antibodies, while the differences in D/
f values were notably larger. The number of FAs was obtained using
vinculin-GFP transfected cells in the presence or absence of anti-
aVb3 antibody after 40 min of spreading. A 3.7-fold lower FA density
was found in anti-aVb3 treated cells than in the control (Fig. 5c, d),
confirming the unavailability of integrins to cluster in focal contacts.
The reduction in the number of FAs seems to correlate better with the
observed D/f differences and suggests that the D/f ratio reflects FAs
maturation and the associated cytoskeletal changes, more than cell
spreading.
Discussion
QCM-D measurements of integrin-mediated cell attachment on
crystals modified with photo-activatable RGD enabled independent
characterization and quantification of integrin-mediated cell binding
and spreading during the early stages of cell adhesion. The photo-
activatable RGD peptide enabled synchronization of the integrin
binding event across the cell layer by a short light exposure when
sedimentation was completed. This method detected differences in
integrin-mediated cell-attachment between different cell types or
from same cell phenotype with different integrin expression levels.
Integrin balance is crucial to maintain the integrity of tissue archi-
tecture, dictating cell adhesiveness and contributing to cell polarity
and functionality by activating specific pathways. For instance, it is
already known the imbalance of b1 and b4 expression in human
breast cancer47 or the expression of avb3 heterodimer seen as a select-
ive cancer stem cell biomarker that leads to therapy resistance48.
Integrins a6 and a3 also contribute to cancer initiation beingmolecu-
lar markers of the aggressive cell phenotype49,50. Differently, activity
of b1-containing integrins modulates cell adhesion and consequent
invasiveness in prostate cancer under higher chemokine levels51. In
general, increased expression and/or activity of integrins within the
primary tumor are associated with poor prognosis and enhanced
metastasis in a variety of cancers52. A recent review clearly describe
the importance of several integrin types involved in the regulation
and progression of cancer53 establishing that a further understanding
is necessary to recognize whether these integrins are interchangeable
or specifically required. On this context, identifying cell integrin
adhesive changes that influence tumor growing and spreading can
lead to discover emerging therapeutic treatments. In this regard, our
platform provides information to characterize cell population adhe-
siveness with the possibility to correlate this with integrin-mediated
tumor aggressiveness integrating expression and activity of these
receptors. Furthermore, the ability to compare the context effect of
integrin adhesion of a normal cellular populationwith a carcinogenic
type can be of great utility to discover specific drugs that reverse this
particular condition.
We envision that this strategy could inspire new integrin-based
diagnostic methods in pathologies involving changes in membrane
integrin expression and avidity. This concept is not only applicable to
RGD as recognition motif, but can be extended to other ligands
specific for membrane receptors.
Methods
Biological reagents. Anti-integrin aVb3 antibody from Millipore (clone 23C6),
cytochalasin D from Sigma (C8273), c[RGDfK] from Peptide International (PCI-
3661-PI, M.W. 603.68). Photo-activatable c[RGD(DMNPB)fK] was synthesized as
previously reported32,54.
Substrate preparation. QSX 301 gold-coated quartz sensors (Q-Sense AB, Västra
Frölunda, Sweden) with a fundamental resonance frequency of about 4.95 MHz were
incubated overnight in a 1 mM mixed solution of 99% HS(CH2)11(OCH2CH2)3OH
and 1% HS(CH2)11 (OCH2CH2)6OCH2COOH thiols (ProChimia TH 001-m11.n3-
0,2 and TH 003-m11.n6-0,1) in absolute ethanol. The substrates were rinsed with
ethanol and Milli-Q water and then incubated in an aqueous solution of 0.2 M EDC
(N-(3-dimethylaminopropyl)-N9-ethylcarbodiimide hydrochloride), 0.1 M NHS
(N-hydroxysuccinimide), 2-(N-morpho)-ethanesulfonic acid (0.1 M) and NaCl
(0.5 M)55. After 15 min, the solution was removed and the substrates were washed
with deionized water and incubated with a solution mix of bovine serum albumin
(BSA, Sigma A2153) and c[RGD(DMNPB)fK] in PBS for 1 h in the dark. The
addition of BSA was necessary to reduce non-specific attachment of cells to the c
[RGD(DMNPB)fK] modified surfaces. The concentration and ratio of BSA and c
[RGD(DMNPB)fK] in the mixture was 0.02 mg/ml of c[RGD(DMNPB)fK] and
0.1 mg/ml BSA. Substrates werewashedwith distilledwater and used immediately for
cell experiments.
Cell culture.Human umbilical vein endothelial cells (HUVEC) were grown in M199
basal medium (Sigma, M4530) supplemented with L-glutamine (2 mM), penicillin
(1000 U/mL), streptomycin (100 mg/L, Sigma), ECGS supplement (Sigma, E-2759),
sodium heparin (Sigma, H-3393) and 20% (v/v) fetal calf serum (FCS) as previously
described56. HUVEC were used at passages 2 to 6. For cell experiments, cells were
treated with 0.25% trypsin and EDTA (1 mM) in Hanks buffer. HT1080 and HeLa
cells were cultured in DMEM medium (Invitrogen) supplemented with 10% (v/v)
FCS, 1% (w/v) L-glutamine from Invitrogen at 37uC in 5% (v/v) CO2. Origin and
cultivation of the human ovarian cancer cell line OV-MZ-657 as well as its integrin
aVb3-mediated adhesive, migratory, and proliferative properties were previously
described58. Stable OV-MZ-6 cell transfectants overexpressing integrin aVb3 were
generated as described earlier59.
QCM-D measurements. QCM-D experiments were performed using a Q-Sense E1
instrument equipped with a window module. The experiments were performed at
37uC in stopped-flow mode. The parameters Df and DD were acquired at six
overtones, i 5 3, 5, to 13, corresponding to resonance frequencies of fi < 15, 25, to
65 MHz simultaneously at sub-second time resolution. Before being inserted in the
chamber, the gold-coated quartz sensors functionalized with cyclo[RGD(DMNPB)
fK] terminated self-assembled monolayers were rinsed with EtOH and dried with N2
stream. During the experiment, the window of the QCM-D chamber was covered by
aluminium foil to avoid photocleavage of the RGD ligand. The QCM-D crystal was
equilibrated in PBS. Cells were injected at a concentration of 3 3 105 cells/ml
empirically determined to result in maximal signals and avoidance of non-specific
cell/surface interactions prior to light irradiation (data not shown). Cells were
injected into the chamber at a flow rate of 300 ml/min for 3 min and incubated in
stop-flow for ca. 30 min. The QCM-D crystal in the QCM-D chamber was irradiated
through the window with a LED (l 5 360 nm, 1.35 mW cm22) for 30 s.
Experiments in the presence of competing soluble cyclic RGD peptides at 10, 25
and 50 mM, cytochalasin D (10 mM) and antibodies rose against integrin aVb3
(10 mM) were performed by injection of cells in the respective solutions containing
these compounds.
Cell transfection and staining. A vinculin-GFP expression plasmid was used to
image vinculin-containing FAs in viable cells. Cells were electroporated using a Lonza
transfection kit P5 (Lonza Group Ltd., Basel, Switzerland). At the end of the
experiment, cells were fixed with methanol for 5 min and the actin cytoskeleton was
stained using TRITC-conjugated phalloidin (Merck-Millipore).
Microscopical monitoring of cell attachment, spreading and focal adhesion
evaluation. Gold coated glass slides functionalized in the same way as QCM-D
www.nature.com/scientificreports
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crystals were incubated with cells and placed in a custom-built set-up stage. Light
exposure for activating the RGD peptide was performed with a LED (l 5 360 nm,
1.35 mW cm22) placed on top of the substrate using themicroscope light path during
30 seconds.Microscopical images were taken every second by anOscar digital camera
(Allied Vision Technologies, Stadtroda, Germany) mounted on a Leica DM-IRB
inverted microscope (Wetzlar, Germany) equipped with a 10 X or 20 X (Leica, NA
0.4). The spreading ratio of the cell was measured in fixed and actin cytoskeleton
stained cells using the software Fiji (ImageJ 2.0.0-beta-7.5) to evaluate the number of
pixels per cell. For the evaluation of number of FA, fixed cells were immunostained
with CD31 antibody (Anti b3, Invitrogen). Number of FA was evaluated using the
software Fiji (ImageJ 2.0.0-beta-7.5)
1. Hood, J. D. & Cheresh, D. A. Role of integrins in cell invasion and migration.
Nature reviews. Cancer 2, 91–100 (2002).
2. Carman, C. V. & Springer, T. A. Integrin avidity regulation: are changes in affinity
and conformation underemphasized? Current opinion in cell biology 15, 547–556
(2003).
3. Bridgewater, R. E., Norman, J. C. & Caswell, P. T. Integrin trafficking at a glance.
J. Cell Sci. 125, 3695–3701 (2012).
4. Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications
and therapeutic opportunities. Nature reviews. Cancer 10, 9–22 (2010).
5. Humphries, J. D., Byron, A. &Humphries, M. J. Integrin ligands at a glance. J. Cell
Sci. 119, 3901–3903 (2006).
6. Reynolds, A. R. et al. Stimulation of tumor growth and angiogenesis by low
concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 15, 392–400
(2009).
7. Takayama, S. et al. The relationship between bone metastasis from human breast
cancer and integrin avb3 expression. Anticancer Res. 25, 79–83 (2005).
8. Danhier, F., Breton, A. L. & Pre´at, V. RGD-based strategies to target alpha(v) beta
(3) integrin in cancer therapy and diagnosis. Mol. Pharm. 9, 2961–2973 (2012).
9. Zhao, H., Wang, J. C., Sun, Q. S., Luo, C. L. & Zhang, Q. RGD-based strategies for
improving antitumor activity of paclitaxel-loaded liposomes in nude mice
xenografted with human ovarian cancer. J Drug Target 17, 10–18 (2009).
10. Bailey, C. L., Kelly, P. & Casey, P. J. Activation of Rap1 promotes prostate cancer
metastasis. Cancer research 69, 4962–4968 (2009).
11. Li, F., Wang, J. H. & Wang, Q. M. Monitoring cell adhesion by using thickness
shear mode acoustic wave sensors. Biosensors & bioelectronics 23, 42–50 (2007).
12. Ergezen, E. et al. Real-time monitoring of adhesion and aggregation of platelets
using thickness shear mode (TSM) sensor. Biosensors & bioelectronics 23,
575–582 (2007).
13. Heitmann, V. & Wegener, J. Monitoring Cell Adhesion by Piezoresonators:
Impact of Increasing Oscillation Amplitudes. Anal Chem 79, 3392–3400 (2007).
14. Hong, S., Ergezen, E., Lec, R. & Barbee, K. A. Real-time analysis of cell-surface
adhesive interactions using thickness shear mode resonator. Biomaterials 27,
5813–5820 (2006).
15. Le Guillou-Buffello, D., Gindre, M., Johnson, P., Laugier, P. & Migonney, V. An
alternative quantitative acoustical and electrical method for detection of cell
adhesion process in real-time. Biotechnology and bioengineering 108, 947–962
(2011).
16.Wang, X., Ellis, J. S., Kan, C. D., Li, R. K. & Thompson, M. Surface immobilisation
and properties of smooth muscle cells monitored by on-line acoustic wave
detector. The Analyst 133, 85–92 (2008).
17. Wegener, J., Janshoff, A. & Galla, H.-J. Cell adhesion monitoring using a QCM:
comparative analysis of different mammallian cell lines. Eur Biophys J 28, 26–37
(1998).
18. Gryte, D. M., Ward, M. D. & Hu, W.-S. Real-time measurement of anchorage-
dependent cell adhesion using a QCM. Biotechnol Prog 9, 105–108 (1993).
19. Redepenning, J., Schlesinger, T. K., Mechalke, E. J., Puleo, D. A. & Bizios, R.
Osteoblasts Attachment monitored with a QCM. Anal Chem 65, 3378–3381
(1993).
20. Seo, J. H. et al. Inducing rapid cellular response on RGD-binding threaded
macromolecular surfaces. Journal of the American Chemical Society 135,
5513–5516 (2013).
21. Tymchenko, N. et al. Reversible changes in cell morphology due to cytoskeletal
rearrangements measured in real-time by QCM-D. Biointerphases 7, 43 (2012).
22. McGrath, J. L. Cell spreading: the power to simplify. Current biology: CB 17,
R357–358 (2007).
23. Cuvelier, D. et al. The universal dynamics of cell spreading. Current biology: CB
17, 694–699 (2007).
24. Byrne, J. D., Betancourt, T. & Brannon-Peppas, L. Active targeting schemes for
nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60, 1615–1626
(2008).
25. Sakamoto, H. et al. Cell-type specific recognition of RGD- and non-RGD-
containing cell binding domains in fibrillin-1. The Journal of biological chemistry
271, 4916–4922 (1996).
26. Lwebuga-Mukasa, J. S. A Mn(21)-enhanced, RGD-dependent adhesion
technique for isolation of adult rat type II alveolar epithelial cells for immediate
functional studies. American journal of respiratory cell and molecular biology 10,
347–354 (1994).
27. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110,
673–687 (2002).
28. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu Rev Cell
Dev Biol 12, 697–715 (1996).
29. Shabbir, S. H., Eisenberg, J. L. & Mrksich, M. An inhibitor of a cell adhesion
receptor stimulates cell migration. Angew. Chem. Int. Ed. 49, 7706–7709 (2010).
30. Wacker, B. K. et al. Endothelial cell migration on RGD-peptide-containing PEG
hydrogels in the presence of sphingosine 1-phosphate. Biophysical journal 94,
273–285 (2008).
31. Liu, S. Radiolabeled multimeric cyclic RGD peptides as integrin avb3 targeted
radiotracers for tumor imaging. Mol. Pharm. 3, 472–487 (2006).
32. Wirkner, M. et al. Photoactivatable Caged Cyclic RGD Peptide for Triggering
Integrin Binding and Cell Adhesion to Surfaces. Chembiochem 12, 2623–2629
(2011).
33. Salierno, M. J., Garcia, A. J. & del Campo, A. Photo-Activatable Surfaces for Cell
Migration Assays. Adv Funct Mater 23, 5974–5980 (2013).
34. Pignataro, B., Steinem, C., Galla, H.-J., Fuchs, H. & Janshoff, A. Specific adhesion
of vesicles monitored by Scanning Force Microscopy and QCM. Biophys. J. 78,
487–498 (2000).
35. Pfeiffer, I., Petronis, S., Köper, I., Kasemo, B. & Zäch, M. Vesicle adsorption and
phospholipid bilayer formation on topographically and chemically
nanostructured surfaces. J Phys Chem B 114, 4623–4631 (2010).
36. Nakayama, Y. &Matsuda, T. In situ observation of dithiocarbamate-based surface
photograf copolymerization using QCM. Macromolecules 32, 5405–5410 (1999).
37. Heeb, R., Bielecki, R. M., Lee, S. & Spencer, N. D. Room-Temperature, Aqueous-
Phase Fabrication of Poly(methacrylic acid) Brushes by UV-LED-Induced,
Controlled Radical Polymerization with High Selectivity for Surface-Bound
Species. Macromolecules 42, 9124–9132 (2009).
38. Marx, K. A., Zhou, T., Warren, M. & Braunhut, S. J. QCM Study of Endothelial
Cell Number Dependent Differences in Initial Adhesion and Steady-State
Behavior: Evidence for cell-cell cooperativity in inital adhesion and spreading.
Biotechno.l Prog. 19, 987–999 (2003).
39. Pietuch, A. & Janshoff, A. Mechanics of spreading cells probed by atomic force
microscopy. Open Biol. 3, 130084 (2013).
40. Xiong, Y. et al. Mechanisms controlling cell size and shape during isotropic cell
spreading. Biophysical journal 98, 2136–2146 (2010).
41. Schoenwaelder, S. M. et al. Phosphoinositide 3-kinase p110 beta regulates integrin
alpha IIb beta 3 avidity and the cellular transmission of contractile forces. The
Journal of biological chemistry 285, 2886–2896 (2010).
42. García, A. J., Huber, F. & Boettiger, D. Force required to break a5b1 integrin-
fibronectin bonds in intact adherent cells is sensitive to integrin activation state.
Journal of Biological Chemistry 273, 10988–10993 (1998).
43. Fredriksson, C., Kihlman, S. & Kasemo, B. In vitro real-time characterization of
cell attachment and spreading. J Mat Sci 9, 785–788 (1998).
44. Nimeri, G. et al. Neutrophil Interactionwith protein-coated surfaces studied by an
extended QCM technique. Colloid Surf B: Biointerfaces 11, 255–264 (1998).
45. Lord, M. S. et al. Extracellular matrix remodelling during cell adhesion monitored
by the quartz crystal microbalance. Biomaterials 29, 2581–2587 (2008).
46. Lord, M. S. et al. Monitoring cell adhesion on tantalum and oxidised polystyrene
using a quartz crystal microbalance with dissipation. Biomaterials 27, 4529–4537
(2006).
47. Nistico, P., Di Modugno, F., Spada, S. & Bissell, M. J. beta1 and beta4 integrins:
from breast development to clinical practice. Breast cancer research: BCR 16, 459
(2014).
48. Kannan, N., Nguyen, L. V. & Eaves, C. J. Integrin beta3 links therapy resistance
and cancer stem cell properties. Nature cell biology 16, 397–399 (2014).
49. Lathia, J. D. et al. Integrin alpha 6 regulates glioblastoma stem cells.Cell stem cell 6,
421–432, doi:10.1016/j.stem.2010.02.018 (2010).
50. Shirakihara, T. et al. Identification of integrin alpha3 as amolecularmarker of cells
undergoing epithelial-mesenchymal transition and of cancer cells with aggressive
phenotypes. Cancer science 104, 1189–1197, doi:10.1111/cas.12220 (2013).
51. Dehghani, M., Kianpour, S., Zangeneh, A. & Mostafavi-Pour, Z. CXCL12
Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of
beta1-Containing Integrins. International journal of cell biology 2014, 981750,
doi:10.1155/2014/981750 (2014).
52. Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications
and therapeutic opportunities. Nature reviews. Cancer 10, 9–22, doi:10.1038/
nrc2748 (2010).
53. Seguin, L., Desgrosellier, J. S., Weis, S. M. & Cheresh, D. A. Integrins and cancer:
regulators of cancer stemness, metastasis, and drug resistance. Trends in cell
biology, doi:10.1016/j.tcb.2014.12.006 (2015).
54. Petersen, S. et al. Phototriggering of Cell Adhesion by CagedCyclic RGDPeptides.
Angewandte Chemie 120, 3236–3239 (2008).
55. Petrie, T. A., Capadona, J. R., Reyes, C. D. & García, A. J. Integrin specificity and
enhanced cellular activities associated with surfaces presenting a recombinant
fibronectin fragment compared to RGD supports. Biomaterials 27, 5459–5470
(2006).
56. Unger, R. E. et al. Isolation andmolecular characterization of brain microvascular
endothelial cells from human brain tumors. In Vitro Cell Dev-An 38, 273–281
(2002).
57. Mobus, V. et al. Morphological, immunohistochemical and biochemical
characterization of 6 newly established human ovarian carcinoma cell lines.
International journal of cancer. Journal international du cancer 52, 76–84 (1992).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9533 | DOI: 10.1038/srep09533 7
58. Hapke, S. et al. Ovarian cancer cell proliferation and motility is induced by
engagement of integrin alpha(v)beta3/Vitronectin interaction. Biological
chemistry 384, 1073–1083 (2003).
59. Hapke, S. et al. Integrin alpha(v)beta(3)/vitronectin interaction affects expression
of the urokinase system in human ovarian cancer cells. The Journal of biological
chemistry 276, 26340–26348 (2001).
Acknowledgments
Authors acknowledge financial support from DFG (CA880/4-1) and CONICET (D.Nu
2332) 2013–2014.
Author contributions
M.S. and J.I. designed the research. J.I., L.G.F. and M.S. conducted the experiments and the
data analysis. A.C., U.R. and A.J.G. supervised the research and contributed with new ideas.
U.R. supplied OV-MZ cells. M.S. and A.C. wrote the manuscript. All authors reviewed the
manuscript.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Iturri, J. et al. Synchronized cell attachment triggered by
photo-activatable adhesive ligands allows QCM-based detection of early integrin binding.
Sci. Rep. 5, 9533; DOI:10.1038/srep09533 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International
License. The images or other third party material in this article are included in the
article’s Creative Commons license, unless indicated otherwise in the credit line; if
the material is not included under the Creative Commons license, users will need
to obtain permission from the license holder in order to reproduce thematerial. To
view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 9533 | DOI: 10.1038/srep09533 8
